logo
An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US

An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US

WIREDa day ago
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for access to an AI-driven but entirely unproven treatment that includes injecting a highly concentrated dose of chlorine dioxide, a toxic bleach solution, directly into cancerous tumors.
One patient tells WIRED her tumor has grown faster since the procedure and that she suspects it may have caused her cancer to spread—a claim Liu disputes—while experts allege his marketing of the treatment has likely put him on the wrong side of US regulations. Nonetheless, while Liu currently only offers the treatment informally in China and at a German clinic, he is now working with a Texas-based former pharmaceutical executive to bring his treatment to America. They believe that the appointment of Robert F. Kennedy Jr. as health secretary will help 'open doors' to get the untested treatment—in which at least one clinic in California appears to have interest—approved in the US.
Kennedy's Make America Healthy Again (MAHA) movement is embracing alternative medicines and the idea of giving patients the freedom to try unproven treatments. While the health secretary did not respond to a request for comment about Liu's treatment, he did mention chlorine dioxide when questioned about President Donald Trump's Operation Warp Speed during his Senate confirmation hearing in February, and the Food and Drug Administration recently removed a warning about substance from its website. The agency says the removal was part of a routine process of archiving old pages on its site, but it has had the effect of emboldening the bleacher community.
'Without the FDA's heavy-handed warnings, it's likely my therapy would have been accepted for trials years earlier, with institutional partnerships and investor support,' Liu tells WIRED. He says he wrote to Kennedy earlier this year urging him to conduct more research on chlorine dioxide. 'This quiet removal won't immediately change everything, but it opens a door. If mainstream media reports on this shift, I believe it will unlock a new wave of serious [chlorine dioxide] research.'
For decades, pseudoscience grifters have peddled chlorine dioxide solutions—sold under a variety of names, such as Miracle Mineral Solution—and despite warnings and prosecutions, have continued to claim the toxic substance is a 'cure' for everything from HIV to Covid-19 to autism. There is no credible evidence to back up any of these claims, which critics have long labeled as nothing more than a grift.
The treatments typically involve drinking liquid chlorine dioxide on a regular basis, using solutions with concentrations of chlorine dioxide of around 3,000 parts per million (ppm), which is diluted further in water.
Liu's treatment, however, involves a much higher concentration of chlorine dioxide—injections of several milliliters of 20,000ppm—and, rather than drinking it, patients have it injected directly into their tumors.
Liu claims he has injected himself with the solution over 50 times and suffered no side effects. 'This personal data point encouraged me to continue research,' he says.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Centene raises Wall Street optimism that Medicaid insurers can improve profits
Centene raises Wall Street optimism that Medicaid insurers can improve profits

Yahoo

time3 minutes ago

  • Yahoo

Centene raises Wall Street optimism that Medicaid insurers can improve profits

By Amina Niasse NEW YORK (Reuters) -Wall Street regained confidence in Medicaid insurers after Centene said on Friday it expects to be able to raise rates charged to states for 2026 health plans for low-income Americans and strengthen profit margins. Insurer shares rose across the board. Centene shares were up 5% in early afternoon trading after falling 16% on the company's announcement of a second-quarter loss and forecast cut. Rivals UnitedHealth, CVS Health and Humana rose 1.61%, 2.69% and 3.45%, respectively. All three report earnings next week. Centene in an earnings call reassured investors it would work with states to ensure their payments for Medicaid plans match the company's increased medical costs for 2026. 'Our goal is to reprice 100%' of plans, said company CEO Sarah London. Insurers are paid a set amount by states for Medicaid plans, which are jointly funded with the federal government. Centene, UnitedHealth and Elevance have said this year that state reimbursements for these plans have lagged behind actual costs of care. Cautious investors have been looking for Medicaid health plan design changes and strategic geographic changes by the companies to reduce use of healthcare services. New work requirements for Medicaid recipients in President Donald Trump's signature tax-cut and spending bill have made some investors worry that healthy people could disenroll in coming years. The bill requires states to verify certain members are working or volunteering a minimum of 80 hours per month to qualify for Medicaid coverage starting in 2027. After a COVID-19 era requirement to keep people enrolled expired in 2023, Medicaid plans redetermined each person's eligibility. This pushed members off, changing the mix of sick and healthy participants, and some Medicaid insurers struggled. 'The Medicaid redeterminations have proven to be far more disruptive than anyone thought," said Jeff Jonas, a portfolio manager at Gabelli Funds. "The entire industry is focused on restoring margin over winning new contracts and membership." More detailed data could justify midyear price increases, said Kevin Gade, chief operating officer at Bahl & Gaynor, and correct mismatched rates set by states after the pandemic. More data over the next year will also enable insurers to improve cost management techniques and raise rates paid by states, Gade said. "With enough data you can take care of the problem.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wellness in 2 Minutes: Micro-Habits for Busy Docs
Wellness in 2 Minutes: Micro-Habits for Busy Docs

Medscape

time28 minutes ago

  • Medscape

Wellness in 2 Minutes: Micro-Habits for Busy Docs

This transcript has been edited for clarity. Wellness does not have to mean an hour at the gym. Let's talk about quick micro-habits you can do in under 2 minutes on a shift. First, box breathing. Inhale for four, hold for four, exhale for four, hold for four. That's a tongue twister. Focusing on your breathing for a little while really helps calm your nervous system. Second, stretch your shoulders and neck, especially if you've been hunched over a computer writing your notes or you have been running nonstop. Third, pause and drink a glass of water. When's the last time you actually hydrated yourself? Fourth, step outside for some fresh air. Spending 30 seconds in the sunlight can really help reset your mood, especially if you're working in a room with no windows. Finally, write down one thing you did well that day. This really helps build confidence and a positive perspective. These tiny resets can really add up, and they're pretty realistic, even on a busy day.

Jaguars DE Josh Hines-Allen says his 7-year-old son Wesley is recovering from leukemia
Jaguars DE Josh Hines-Allen says his 7-year-old son Wesley is recovering from leukemia

Associated Press

time36 minutes ago

  • Associated Press

Jaguars DE Josh Hines-Allen says his 7-year-old son Wesley is recovering from leukemia

JACKSONVILLE, Fla. (AP) — Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from cancer. Hines-Allen and his wife, Kaitlyn, provided the news in a three-minute video released on social media. They said the diagnosis of acute promyelocytic leukemia came after Wesley spiked a fever and started bleeding from a tooth days before last year's season finale, which Hines-Allen missed for personal reasons. 'It just kind of like hit me, and then nothing else mattered after that,' Hines-Allen said in the video. Wesley underwent chemotherapy for six months. He has a few treatments remaining before he gets to ring the bell next month at Nemours Children's Health in Jacksonville. 'Wesley is doing great,' Kaitlyn said in the video. 'He's swimming every day. He's running around. He's playing sports.' Added Hines-Allen: 'He's got back to being the big brother that he is.' Hines-Allen and his wife also announced Friday that their nonprofit foundation, Four One For All, will launch a season-long campaign called 'Four One For Hope' to give back to four cancer-focused non-profits each month of the NFL regular season. Money raised will go to Nemours Children's Hospital in September, the American Cancer Society in October, the Ronald McDonald House Charities of Jacksonville in October and the National Pediatric Cancer Foundation in December. 'Our goal is to ensure that families going through something similar feel the same level of love and support as we did,' Hines-Allen said in a statement. Hines-Allen is a two-time Pro Bowl pass rusher who has 53 career sacks in six seasons in Jacksonville, two shy of the franchise record held by Tony Brackens. He signed a five-year, $141.25 million contract that included $76.5 million fully guaranteed before the 2024 season. ___ AP NFL:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store